Relapsed/Refractory Multiple Myeloma Patients. a Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy

被引：0
|
作者：
Fazio, Francesca [1 ]
Di Rocco, Alice [1 ]
Za, Tommaso [2 ]
Tomarchio, Valeria [3 ]
Rago, Angela [4 ]
Piciocchi, Alfonso [5 ]
di Toritto, Tommaso Caravita
Annibali, Ombretta [3 ]
De Stefano, Valerio [2 ]
Foa, Robin [1 ]
Martelli, Maurizio [1 ]
Petrucci, Maria Teresa [1 ]
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Azienda Osped Policlin Umberto 1, Hematol, Rome, Italy
[2] Catholic Univ, Sect Hematol, Dept Radiol & Hematol Sci, Fdn Policlin A Gemelli, Rome, Italy
[3] Univ Campus Bio Medico, Hematol Unit, Stem Cell Transplantat, Rome, Italy
[4] UOSD Ematol ASL Roma 1, Rome, Italy
[5] Italian Grp Adult Hematol Dis GIMEMA, Rome, Italy
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149547
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3755
引用
收藏
页码：3755 / +
页数：5
相关论文
共 50 条
  • [21] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [22] Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet need
    Martin, Yasmine St.
    Franz, Joseph K.
    Agha, Mounzer E.
    Lazarus, Hillard M.
    BLOOD REVIEWS, 2023, 60
  • [23] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [24] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [25] A suggestion to improve the results of “Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma”
    Majid Arash
    Clinical and Experimental Medicine, 24 (1)
  • [26] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
    Feng, Deming
    Sun, Jian
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
  • [27] CD19 CAR T-Cell Therapy in Patients with Relapse/Refractory DLBCL: Retrospective Analysis of the Eligibility Criteria
    Paillassa, Jerome
    Di Blasi, Roberta
    Chevret, Sylvie
    Bernard, Sophie
    Darmon, Michael
    Meignin, Veronique
    Deau-Fischer, Benedicte
    Camus, Vincent
    Casasnovas, Rene-Olivier
    Cartron, Guillaume
    Chaoui, Driss
    Delwail, Vincent
    Feugier, Pierre
    Fornecker, Luc Mathieu
    Gyan, Emmanuel
    Haioun, Corinne
    Kuhnowski, Frederique
    Malfuson, Jean Valere
    Marolleau, Jean-Pierre
    Morel, Veronique
    Damaj, Gandhi
    Quinquenel, Anne
    Rigaudeau, Sophie
    Salanoubat, Celia
    Salmeron, Geraldine
    Sibon, David
    Azoulay, Elie
    Berquier, Maxime
    Thieblemont, Catherine
    BLOOD, 2019, 134
  • [28] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
  • [29] A Preliminary Study on the Safety and Efficacy of a Novel Human BCMATargeting CAR-T Therapy in Patients with Relapsed/Refractory Multiple Myeloma
    Wang, Yi
    Gao, Ying
    Wang, Hui
    Zhang, Ding
    Zheng, Yan
    Hu, Xingxing
    Gao, Qiuying
    Niu, Ben
    Zhang, Hong
    Zhou, Wei
    Zhang, Weihua
    Ru, Xingli
    Wang, Fangyuan
    BLOOD, 2021, 138
  • [30] BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
    Yuhan Yan
    Yixuan Tu
    Qian Cheng
    Jian Zhang
    Erhua Wang
    Zuqun Deng
    Yan Yu
    Liwen Wang
    Rui Liu
    Ling Chu
    Liqing Kang
    Jing Liu
    Xin Li
    Journal of Translational Medicine, 22 (1)
12345